|
⚲
|
| Keyboard |
| Merriweather Alfred G
✚
|
|
|---|---|
| CIK # | 0001211839 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001211839] | |
| 4 | [0001211839] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Merriweather Alfred G | |
| Adamas Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-09-20 | Sell | 1,584 | $6.91 | 10,945 |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2019-04-08 | Grant | 50,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-04-08 | Grant | 25,000 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2019-03-20 | Sell | 857 | $7.99 | 6,847 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2018-09-21 | Sell | 1,665 | $19.18 | 31,935 |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2018-03-06 | Grant | 50,250 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2018-03-06 | Grant | 8,375 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2017-07-10 | Grant | 18,750 | $0.00 | |
|
Adamas Pharmaceuticals Inc ADMS
Stock Option (Right to Buy) · derivative
|
2017-07-10 | Grant | 112,500 | $0.00 |